T1	Participants 322 436	Fifty-six patients (49 boys, 7 girls, mean age = 6.4 years, SD = 2.7) enrolled in an open-label trial of secretin,
T2	Participants 1150 1270	17 of the most responsive patients from Study 1 began a double-blind trial that also included 8 newly enrolled patients.
